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Abstract. 
We performed a descriptive analysis of acute and potentially life-threatening tropical diseases among 
82,825 ill western travelers reported to GeoSentinel from June of 1996 to August of 2011. We 
identified 3,655 patients (4.4%) with a total of 3,666 diagnoses representing 13 diseases, including 
falciparum malaria (76.9%), enteric fever (18.1%), and leptospirosis (2.4%). Ninety-one percent of the 
patients had fever; the median time from travel to presentation was 16 days. Thirteen (0.4%) patients 
died. Ten patients had falciparum malaria, 2 patients had melioidosis, and 1 patient had severe dengue. 
Falciparum malaria was mainly acquired in West Africa, and enteric fever was largely contracted on 
the Indian subcontinent; leptospirosis, scrub typhus, and murine typhus were principally acquired in 
Southeat Asia. Western physicians seeing febrile and recently returned travelers from the tropics need 
to consider a wide profile of potentially life-threatening tropical illnesses, with a specific focus on the 
most likely diseases described in our large case series. 
INTRODUCTION 
Each year, an estimated 50 million travelers from Western countries visit tropical 
regions of the world, and these numbers are rapidly growing.1 This travel is a modern 
phenomenon, because only a few generations ago, many parts of the tropics were 
virtually inaccessible to Western travelers because of the presence of potentially fatal 
tropical diseases. Vivid historical examples include the ill-fated 1874–1877 Henry 
Morton Stanley trans-African expedition, during which two-thirds of the participants 
died of malaria, sleeping sickness, and other conditions, and the French attempt to 
construct the Panama Canal in the 1880s, an endeavor that was aborted because of 
heavy human losses from malaria and yellow fever.2 
Even in the 21st century, western travelers can contract tropical diseases that, if 
left untreated, can be fatal within the first few weeks of symptom onset. Given the 
potentially serious consequences for the patients and in some cases, their close 
contacts and healthcare workers,3 it is important that life-threatening tropical diseases 
are swiftly diagnosed. However, a low index of suspicion, especially in the primary 
care setting, and limited availability of diagnostic tests may preclude optimal 
management of these diseases, which are unfamiliar to most western physicians. 
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With the exception of falciparum malaria, enteric fever, and rickettsioses,4–6 
current data on severe tropical diseases in travelers are scarce and usually confined to 
single case reports and smaller case series.3,7,8 Here, we describe all cases of acute and 
potentially life-threatening tropical diseases in western travelers reported to the 
GeoSentinel Surveillance Network from June of 1996 to August of 2011. 
MATERIALS AND METHODS 
Data source. 
GeoSentinel is a global network (www.geosentinel.org) established in 1995 
through the International Society of Travel Medicine and the Centers for Disease 
Control and Prevention with the goal of monitoring travel-related morbidity. 
Currently, 57 GeoSentinel travel and tropical medicine clinics, located in 26 countries 
on six continents, contribute clinician-based anonymous information on ill travelers. 
Most reported cases are seen at the GeoSentinel sites, but sites can also report cases 
that they have been consulted about at other institutions. Data, entered in a structured 
query language database at a central data center, include presenting symptoms, 
demographic information, history of recent travel, reason for travel, outpatient or 
inpatient status, whether the patient was seen during or after travel, independent 
versus organized travel, whether the patient had a pre-travel encounter with a 
healthcare provider, diagnosis, and outcome. To be included in the database, patients 
must have crossed an international border within 10 years of presentation and must be 
seeking medical care for a presumed travel-related illness. All GeoSentinel sites use 
the best available reference diagnostic methods in their own country. The diagnosis of 
each case may be reported as confirmed, probable, or suspected, and it is selected 
from a standardized list of > 500 etiologic and syndromic diagnoses. A patient might 
receive several diagnoses. Non-fatal complications are not systematically reported; 
the major exception is malaria and dengue, for which complications (e.g., cerebral 
malaria and dengue hemorrhagic fever/dengue shock syndrome [DHF/DSS]) are 
routinely reported. Outcomes are categorized as either survival or death.9 
Inclusion criteria and definitions. 
We performed a descriptive analysis based on data entered into the GeoSentinel 
database from June of 1996 to August of 2011. Only ill travelers who lived in North 
America, Europe, Israel, Japan, Australia, and New Zealand and were seen during or 
after travel to Central and South America, Africa, Oceania, and tropical and 
subtropical parts of Asia with a confirmed or probable diagnosis of an acute and 
potentially life-threatening tropical disease were included in the analyses. Travelers 
with immigration as a sole reason for travel were excluded. An acute and potentially 
life-threatening tropical disease was defined as an infectious disease that, as of this 
writing, is largely confined to tropical and subtropical areas of the world, with an 
incubation period of < 4 weeks and an estimated > 5% risk of death within 4 weeks 
after symptom onset if left untreated. In the GeoSentinel diagnosis list, 21 diseases 
fulfill these criteria, including 6 viral infections or syndromes, 12 bacterial infections, 
and 3 protozoan infections (Table 1). Cases of spotted fever group rickettsiosis were 
included only if they were acquired outside sub-Saharan Africa, where the benign 
African tick bite fever is the predominant disease.10 The microbiological diagnostic 
methods varied according to the infection and included blood smears (for malaria, 
relapsing fever, and East African sleeping sickness), immunochromatography tests 
(for falciparum malaria and dengue), bacteriologic cultures (for typhoid and 
paratyphoid fever and melioidosis), serology (for leptospirosis, rickettsiosis, and viral 
infections), and polymerase chain reaction (PCR; for knowlesi malaria, relapsing 
fever, and viral infections). Complicated malaria and DHF/DSS were diagnosed 
according to World Health Organization (WHO) criteria.11,12 A confirmed case was 
defined as illness in a traveler with a pertinent travel history and presentation plus 
microbiological test results supporting recent infection; a probable case was defined 
as illness in a traveler with pertinent travel history and presentation but inconclusive 
or unavailable microbiology test results and no plausible alternate diagnosis. 
Individual countries were grouped according to the United Nations region and 
subregion system.13 Classification of reason for travel related to current disease was 
grouped into four categories: tourism, business, visiting friends and relatives (VFR), 
and other reason, including foreign aid and missionary or military deployment. 
Statistical analysis. 
For each life-threatening diagnosis, a descriptive analysis was performed on 
demographics and trip characteristics. Time from travel to clinic visit was estimated 
for post-travel cases only. Simple frequency statistics and percentages were calculated 
for categorical variables, and median and range statistics were calculated for 
continuous variables. All data were analyzed by using the SAS software (version 9.2). 
RESULTS 
We identified 82,825 ill western travelers with exposure in tropical and 
subtropical regions who had sought medical care or were consulted at a GeoSentinel 
site from June of 1996 to August of 2011. Of these travelers, 3,655 (4.4%) patients 
with 3,666 diagnoses had an acute and potentially life-threatening disease, the four 
most common conditions being falciparum malaria (76.9%), typhoid fever (11.7%), 
paratyphoid fever (6.4%), and leptospirosis (2.4%). The complete list of diagnoses 
with accumulated number totals is presented in Figure 1. Demographic, travel 
characteristics, and hospitalization and death totals are shown in Table 2; 91% of the 
patients had fever, 60% of patients were hospitalized, and 0.4% of patients died. The 
geographic distribution of acquisition of the four most common diagnoses is depicted 
in Figure 2. There were no cases of anthrax, plague, Carrion’s disease (Bartonella 
bacilliformis infection), epidemic typhus, diphtheria, avian influenza, Lassa or other 
African hemorrhagic fevers, yellow fever, Rift Valley fever, or tropical 
encephalitides, except for a single case of Japanese encephalitis. Cases were reported 
from all 57 GeoSentinel sites: 62% of the cases were reported from sites in Europe, 
20% of the cases were reported from North America, 4% of the cases were reported 
from New Zealand/Australia, and 14% of the cases were reported from other regions. 
Data were largely complete for key variables (age = 98.9%, sex = 99.6%, and purpose 
of travel = 99.9%) but less complete for some supplementary information (pre-travel 
encounter = 93.6%). 
Table 3 presents data for the viral infections examined. DHF/DSS was diagnosed 
in 18 travelers, which constitutes 0.9% of all dengue cases (N = 1,910) among western 
travelers reported to GeoSentinel network during the study period; one-third of the 
DHF/DSS cases were reported from Thailand. A Norwegian female tourist in her 
fifties who was infected in March of 2008 in Phuket, Thailand, died of PCR-
confirmed DHF/DSS. One case of non-fatal serologically confirmed Japanese 
encephalitis was reported in a female Canadian tourist in her twenties after a 4-week 
trip to Thailand in September of 2010. 
Selected data for the 820 cases of bacterial disease are presented in Table 4. 
Among the patients with the 428 cases of typhoid fever, the two most common 
reasons for travel were tourism and VFR travel; most of cases were acquired in South 
Central Asia (India, N = 147, 34% of total; Nepal, N = 55, 13%; Pakistan, N = 28, 7%; 
and Bangladesh, N = 26, 6%). Of the 210 travelers with paratyphoid fever, 79% were 
infected in South Central Asia (India, N = 79, 38% of total; Nepal, N = 63, 30%; 
Pakistan, N = 22, 10%; and Bangladesh, N = 11, 5%). Leptospirosis was diagnosed in 
88 travelers, of whom 82% were tourists; most cases were acquired in Southeast Asia 
(Thailand, N = 19, 22% of total; Laos, N = 11, 13%; Indonesia, N = 6, 7%). 
Rickettsioses were seen in 58 travelers, including 29 cases of spotted fever group 
rickettsiosis acquired outside sub-Saharan Africa, 16 cases of murine typhus, and 13 
cases of scrub typhus. Most cases were seen in tourists. Although spotted fever group 
rickettsiosis was seen after travel to several regions, murine typhus and scrub typhus 
were largely confined to travelers to Southeast Asia. Relapsing fever was seen in 
seven travelers, of whom five were exposed in sub-Saharan Africa. Melioidosis was 
diagnosed in six patients, of whom a 35-year-old male French tourist to Martinique 
and a 57-year-old male Australian business traveler to Phuket, Thailand, had 
septicemia and died. 
Table 5 presents selected data for the 2,827 patients with protozoan diseases. 
Falciparum malaria was mainly seen in males, with the three most common reasons 
for travel being VFR, tourism, and business. Fifty-four percent of the cases were 
acquired in West Africa (Ghana, N = 380, 13% of total; Nigeria, N = 294, 10%; and 
Côte d’Ivoire, N = 195, 7%). Of the 177 (6.3%) patients who developed complicated 
malaria, 46 (26%) patients were VFR travelers. Ten (0.4%) patients died; among VFR 
cases, the fatality rate was 1/1,572 (0.06%). The single case of knowlesi malaria was 
seen in a 40-year-old New Zealand male business traveler to Bintalu, Sabah State, 
Malaysia, who had complicated disease. The six travelers with East African sleeping 
sickness (Trypanosoma brucei rhodesiense infection) were infected in Tanzania (N = 
2), Kenya (N = 1), Zambia (N = 2), and Zimbabwe (N = 1). The last three cases were 
reported from GeoSentinel sites in Canada, the United Kingdom, and the United 
States from August 24 to November 15, 2010, and they occurred in safari tourists to 
South Luangwa National Park and South Luangwa Valley in southern Zambia and 
Mana Pools National Park in northern Zimbabwe. Five of six persons were 
hospitalized, and all survived. 
DISCUSSION 
Since colonial times, the risk for western travelers of contracting potentially 
severe tropical disease has dramatically declined, largely because of containment of 
these diseases in many endemic areas and better protection of travelers by education, 
immunization, and use of chemoprophylaxis. The risk, however, is never nil, and the 
number of travelers to tropical areas is increasing; sub-Saharan Africa and Southeast 
Asia, in particular, have shown a strong growth in tourist travel.1 In our study, which 
is based on the largest cases series available of ill western travelers with exposure in 
the tropics and subtropics, the proportion of acute and potentially life-threatening 
tropical disease was as high as 4.6%. 
A common perception is that VFRs and long-stay travelers, such as missionaries, 
aid workers, and volunteers, would be most susceptible to serious exotic infections. 
Indeed, in this study, less than 30% of travelers overall were standard tourists. 
However, this percentage is mostly because of the large number of falciparum malaria 
cases in the study cohort, where VFR travelers have a large predominance. For many 
other acute and potentially life-threatening diseases, standard tourists (i.e., the traveler 
type most commonly seen in the pre-travel consultation context) predominate: typhoid 
fever (49%), paratyphoid fever (56%), leptospirosis (82%), rickettsioses (69%), 
melioidosis (50%), and severe dengue (50%). 
Among the > 82,000 ill western travelers evaluated in our study, no cases were 
reported of much-feared tropical viral infections such as yellow fever, Lassa fever, 
and Ebola virus infection. Actually, the prevalence among ill travelers reported to 
GeoSentinel of potentially severe viral disease was very low, and we detected only 1 
case of Japanese encephalitis and 18 cases of DHF/DSS. The rarity of viral 
hemorrhagic fevers as a cause of imported fever has been emphasized by others and 
should be borne in mind when making a risk assessment about investigation, 
management and possible isolation of a febrile returned traveler. National guidelines 
for dealing with febrile travelers usually focus on the potential severity of a viral 
hemorrhagic fever and reduction of the risk of potential nosocomial transmission 
rather than its extreme rarity.14 
We identified 867 cases of potentially life-threatening bacterial diseases. The most 
commonly seen entity, enteric fever caused by Salmonella enterica serotype Typhi 
and S. enterica serotype Paratyphi, has an untreated mortality rate in the range of 10–
20%, which is indicated by studies from the pre-antibiotic era.15 However, consistent 
with recent studies from developed countries,16,17 no fatalities were identified among 
the 661 patients in this analysis, a finding that may reflect the efficacy of modern 
treatment of  enteric fever. Most of our cases were acquired by males and travelers to 
the Indian subcontinent, but in contrast to other studies,16–18 we identified most cases 
in tourists and relatively fewer among VFR travelers. The proportion of S. enteric 
serotype Paratyphi infection in this case series highlights this pathogen as an 
emerging infection throughout the Indian subcontinent for which vaccine is not 
available.5,19 
Our 88 cases of leptospirosis, a zoonosis caused by various members of the 
Leptospira species and typically acquired during freshwater activities such as rafting 
and swimming, were largely seen in males, tourists, and persons traveling to 
Southeast Asia. This finding is consistent with the findings of a recent Israeli study, 
where most of the patients were male tourists infected in the Mekong River in Laos.20 
None of our patients reportedly died, but untreated cases infected with certain 
serogroups (e.g., L. icterohaemorrhagiae) may carry a substantial mortality. 
Rickettsioses are vector-borne bacterial diseases that typically present as an acute 
febrile illness with constitutional symptoms and skin eruptions. Most travel-associated 
cases represent the benign African tick bite fever caused by Rickettsia africae and are 
acquired in rural sub-Saharan Africa,10 but occasionally, travelers to other destinations 
may contract potentially life-threatening rickettsioses, such as scrub typhus, 
Mediterranean spotted fever, Indian tick typhus, and murine typhus.6 Most of our 58 
cases of rickettsioses were acquired by tourists. Whereas spotted fever group 
rickettsiosis was acquired in diverse regions, scrub typhus and murine typhus were 
largely confined to visitors to Southeast Asia. Forty percent of our cases with 
rickettsioses were hospitalized, but no fatalities were identified, a finding that, in part, 
may be explained by the frequent empiric use of doxycycline in cases of suspected 
rickettsial infection at GeoSentinel sites.6 
Melioidosis caused by Burkholderia pseudomallei, a motile gram-negative rod 
found in soil and surface water in tropical Asia, northern Australia, and Latin 
America, is rarely seen in western travelers.7 Melioidosis may have a dramatic course, 
with rapid clinical deterioration and fatal outcome. Two of our six cases died with 
septicemia, underscoring that clinicians seeing returnees from endemic areas with 
fulminant bacterial infections should consider the possibility of acute melioidosis and 
institute an antipseudomonal antibiotic (e.g., ceftazidime or a carbapenem).21 
Falciparum malaria was overwhelmingly the most commonly imported potentially 
severe tropical disease in our study. Cases were primarily seen among males, VFR 
travelers, and visitors to West Africa, a finding that suggests that health education is 
particularly inadequate for some ethnic minorities visiting their countries of origin 
and that stronger efforts to reach these risk groups are needed. As in a United 
Kingdom study of > 24,000 cases seen from 1987 to 2006, we found that a significant 
proportion of cases were acquired in Nigeria, Ghana, and Côte d’Ivoire, none of 
which are typical tourist destinations.4 Similarly, in a large analysis of > 12,000 cases 
of imported pediatric malaria, the main risk areas were VFR destinations rather than 
tourist targets.22 Immigrants from endemic areas may consider malaria a benign 
condition, but it should be noted that 26% of our cases with complicated falciparum 
malaria did occur in this particular subgroup of travelers. Still, only 0.06% of our 
VFR patients with falciparum malaria are known to have died. This percentage is 
even lower than in a recent large United Kingdom survey on imported malaria, where 
the fatality rate was 0.32% among VFR travelers.23 We assume that such findings 
might be explained by a high proportion of some degree of immunity combined with 
rapid and proper medical management at many western hospitals.24,25 In our study, 
males represented 67% of the falciparum malaria cases. This finding is consistent 
with an Israeli study on post-travel–related hospitalization, where 75% of malaria 
cases were seen in males,26 and it probably reflects different risk-taking behaviors 
between the sexes. 
We detected six cases of East African sleeping sickness, a disease that, in contrast 
to its West African counterpart (T. brucei gambiense infection), may be fatal within a 
few weeks if not properly managed. Interestingly, three of our cases were reported 
within less than 3 months in 2010 and occurred in safari tourists to nearby areas in 
northern Zimbabwe and southern Zambia. Two additional cases infected in the same 
region were reported by others,27 but whether these five cases in close temporal 
proximity represent sentinel events for increased focal activity in the South Luangwa 
Valley or reflect increased incursions by travelers into this sparsely populated area is 
unknown. Only four other travel-related cases infected in this region were reported to 
the WHO during the past decade (Simarro P, personal communication). 
To swiftly diagnose and properly manage acute and potentially fatal tropical 
diseases in returning travelers is one of the most important tasks in post-travel 
medicine. Given the huge numbers of ill returnees presenting with various symptoms, 
this endeavor may seem impossible. However, our study may provide some useful 
hints. First, all cases had a median time lag from travel to clinic visit of less than 17 
days, and 91% of the patients had fever. Thus, when evaluating ill travelers from the 
tropics, the attending physician should always initially focus on recent returnees who 
present with a febrile illness not obviously explained by other causes. Second, 
consistent with a previous GeoSentinel paper,9 our study suggests that the spectrum of 
acute and potentially life-threatening tropical diseases illness varies with the type of 
traveler and the geographic destination. Although falciparum malaria was mainly 
acquired by males, VFR travelers, and visitors to West Africa, enteric fever was 
largely seen in VFR travelers, tourists, and visitors to the Indian subcontinent. 
Likewise, leptospirosis, scrub typhus, and murine typhus were typically contracted by 
males, tourists, and travelers to Southeast Asia. 
That said, infections with a global distribution (such as meninogococcemia and 
other forms of septicemia and severe bacterial pneumonia, including legionnaires) can 
also be life-threatening and must be considered by clinicians evaluating febrile 
returnees. These cosmopolitan infections can account for one-third or more of patients 
hospitalized with fever post-travel.28 Clinicians must focus on all potentially life-
threatening infections and not just the less familiar tropical ones. 
The limitations of this study are shared by other reports published by the 
GeoSentinel network.6,9,25,28 Because most GeoSentinel sites are located within 
academic medical institutions, our data may be biased to unusual or complicated cases 
and may not reflect the typical pattern of disease seen by general practitioners. The 
seemingly high proportion of benign clinical courses could be explained by the 
protocols at some high-volume GeoSentinel sites that see mainly outpatients, where 
subsequent hospitalizations might not be captured and reported to GeoSentinel. 
Therefore, the low rate of hospitalization and death should not necessarily be 
interpreted as most cases were of mild severity. The seemingly long time from 
symptom onset to clinic visit for some cases can be explained by the fact that most 
GeoSentinel sites also act as referral centers, to which patients are referred for a 
second opinion sometimes weeks or months after the acute illness. A major strength 
of our study is the detail in core epidemiologic factors, such as sex, age, reason for 
travel, and travel destination, for these life-threatening diseases. 
In summary, our study suggests that clinicians need to consider a wide range of 
potentially life-threatening tropical infections in recently returned febrile travelers 
from the tropics and subtropics based on sex, reason for travel, and destination. 
Despite marked improvements in diagnostic and therapeutic options, deaths do still 
occur and can be prevented only if astute clinicians consider, diagnose, and treat these 
conditions rapidly. 
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FIGURE 1. Total cases of acute and potentially life-threatening diseases (N = 3,666) among 82,825 ill 
western travelers to the tropics: data from the GeoSentinel surveillance network, 1996–2011. 
FIGURE 2. Number of cases of selected acute and potentially life-threatening diseases by exposure 
region among 82,825 ill western travelers to the tropics: data from the GeoSentinel surveillance 
network, 1996–2011. This figure appears in color at www.ajtmh.org. 
TABLE 1  
Infections and syndromes included in life-threatening tropical diseases in western travelers: data from 




Lassa fever and other tropical hemorrhagic fevers 
Japanese encephalitis and other tropical encephalitides 
Rift Valley fever 












Spotted fever group rickettsioses† 
Bacterial infections 
Typhoid fever 




* Bartonella bacilliformis infection. 
† Only cases acquired outside sub-Saharan Africa. 
‡ T. brucei rhodesiense infection. 
TABLE 2  
Total cases of acute and potentially life-threatening diseases (N = 3,666) among 82,825 ill western 
travelers to the tropics: data from the GeoSentinel surveillance network, 1996–2011 
 n (%) 
Total number of patients 3,655 
Age (median; range in years) 35 (0–80) 
Males 2,381 (65) 
Reason for travel  
 Tourism 1,009 (28) 
 Business 453 (12) 
 VFR 1,765 (48) 
 Other 426 (12) 
Pre-travel consultation 1,210 (35) 
Exposure region  
 Caribbean 69 (2) 
 Central America 51 (1) 
 Middle East 8 (< 1) 
 North Africa 37 (1) 
 Northeast Asia 8 (< 1) 
 Oceania 30 (1) 
 South America 46 (1) 
 South Central Asia 515 (14) 
 Southeast Asia 193 (5) 
 Sub-Saharan Africa 2,700 (74) 
Hospitalizations 2,180 (60) 
Deaths 13 (< 1) 
TABLE 3 
Cases of acute and potentially life-threatening viral diseases (N = 19) among 82,825 ill western 
travelers to the tropics: data from the GeoSentinel surveillance network, 1996–2011 
 DHF/DSS* Japanese encephalitis 
Total number of cases 18 1 
Age (median; range in years) 28.5 (0–60) 26 (NA) 
Time to presentation (median; range in days)† 6.5 (0–181) NA 
Males (n, %) 8 (47) 0 
Reason for travel (n, %)   
 Tourism 9 (50) 1 
 Business 1 (6) 0 
 VFR 5 (28) 0 
 Other 3 (17) 0 
Pre-travel consultation (n, %) 5 (33) 0 
Exposure region (n, %)   
 Caribbean 5 (28) 0 
 Central America 0 (0) 0 
 Middle East 0 (0) 0 
 North Africa 0 (0) 0 
 Northeast Asia 0 (0) 0 
 Oceania 0 (0) 0 
 South America 0 (0) 0 
 South Central Asia 4 (22) 0 
 Southeast Asia 9 (50) 1 
 Sub-Saharan Africa 0 (0) 0 
Hospitalizations (n, %) 13 (76) 1 
Death (n, %) 1 (6) 0 
NA = not applicable. 
* WHO criteria. 
† For cases seen post-travel only. 
TABLE 4  
Cases of acute and potentially life-threatening bacterial diseases (N = 820) among 82,825 ill western 















of cases 428 233 88 29 16 13 7 6 
Age (median; 
range in years) 
28 (1–



















Males (n, %) 232 (54) 137 (59) 72 (82) 16 (55) 8 (50) 9 (69) 5 (71) 5 (83) 
Reason for 
travel (n, %)         
 Tourism 210 (49) 131 (56) 71 (82) 20 (69) 9 (56) 11 (85) 2 (43) 3 (50) 
 Business 36 (8) 17 (7) 8 (9) 4 (14) 0 (0) 2 (15) 1 (14) 3 (50) 
 VFR 123 (28) 54 (23) 3 (4) 4 (14) 3 (19) 0 (0) 1 (14) 0 (0) 





(40) 113 (53) 32 (40) 12 (43) 5 (33) 6 (50) 3 (43) 1 (20) 
Exposure 
region (n, %)         
 Caribbean 10 (2) 1 (< 1) 7 (8) 2 (7) 0 (0) 0 (0) 0 (0) 1 (17) 
 Central 
America 25 (6) 1 (< 1) 15 (17) 4 (14) 1 (6) 0 (0) 0 (0) 0 (0) 
 Middle East 1 (< 1) 4 (2) 0 (0) 1 (4) 0 (0) 0 (0) 1 (14) 0 (0) 
 North 
Africa 1 (< 1) 3 (1) 3 (3) 5 (17) 1 (6) 0 (0) 1 (14) 0 (0) 
 Northeast 
Asia 3 (1) 1 (< 1) 0 (0) 3 (10) 0 (0) 0 (0) 0 (0) 0 (0) 
 Oceania 1 (0.3) 0 (0) 2 (2) 1 (4) 0 (0) 0 (0) 0 (0) 0 (0) 
 South 




(67) 185 (79) 3 (3) 6 (21) 1 (6) 2 (15) 0 (0) 0 (0) 
 Southeast 
Asia 45 (11) 21 (9) 49 (56) 5 (17) 10 (63) 10 (77) 0 (0) 4 (67) 
 Sub-Saharan 




(45) 133 (57) 44 (50) 13 (45) 8 (50) 2 (15) 6 (86) 4 (67) 
Death (n, %) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 2 (33) 
NA = not applicable. 
* For cases exposed outside of sub-Saharan Africa. 
† For cases seen post-travel only. 
TABLE 5  
Cases of acute and potentially life-threatening protozoan diseases (N = 2,827) among 82,825 ill western 
travelers to the tropics: data from the GeoSentinel surveillance network, 1996–2011 
 Falciparum 
malaria Knowlesi malaria 
East African 
trypanosomiasis 
Total number of cases 2,820 1 6 
Age (median; range in years) 37 (0–80) 40 (NA) 45.5 (31–71) 
Time to presentation (median; range in days)* 10 (1–341) 22 (NA) 6 (1–38) 
Males (n, %) 1,890 (67) 1 3 (50) 
Reason for travel (n, %)    
 Tourism 541 (19) 0 5 (83) 
 Business 381 (14) 1 1 (17) 
 VFR 1572 (56) 0 0 (0) 
 Other 323 (11) 0 0 (0) 
Pre-travel consultation (n, %) 879 (33) 0 2 (33) 
Exposure region (n, %)    
 Caribbean 43 (2) 0 0 (0) 
 Central America 5 (< 1) 0 0 (0) 
 Middle East 1 (< 1) 0 0 (0) 
 North Africa 23 (1) 0 0 (0) 
 Northeast Asia 1 (< 1) 0 0 (0) 
 Oceania 26 (1) 0 0 (0) 
 South America 17 (1) 0 0 (0) 
 South Central Asia 33 (1) 0 0 (0) 
 Southeast Asia 38 (1) 1 0 (0) 
 Sub-Saharan Africa† 2,633 (93) 0 6 (100) 
 Western Africa 1,527   
 Central Africa 349   
 Eastern Africa 286   
 Northern Africa 23   
 Southern Africa 11   
Hospitalizations (n, %) 1,765 (63) 0 5 (83) 
Complicated malaria‡ (n, %) 177 (6) 1 NA 
Deaths (n, %) 10 (< 1) 0 0 (0) 
NA = not applicable. 
* For cases seen post-travel only. 
† Sub-Saharan Africa categories based on United Nations region. 
‡ WHO criteria.9 
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